Search alternatives:
significant progressive » significant progress (Expand Search), significant protective (Expand Search), significant processes (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
progressive decrease » progressive decline (Expand Search)
significant progressive » significant progress (Expand Search), significant protective (Expand Search), significant processes (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
progressive decrease » progressive decline (Expand Search)
-
361
-
362
-
363
-
364
-
365
The effect of pre-RT D-dimer levels on post-RT changes in D-dimer levels and on survival rates.
Published 2025Subjects: -
366
-
367
-
368
Kaplan Meier curves of OS and PFS according to different pre-RT different D-dimer values.
Published 2025Subjects: -
369
-
370
-
371
-
372
-
373
-
374
-
375
-
376
Measurement of Na<sup>+</sup> ratio in the TE and blastocyst cross-sectional area in the ouabain-treated group.
Published 2025“…The Na<sup>+</sup> concentration patterns were categorized into two main types: a decrease followed by an increase (Embryo Nos. 1, 3, 7, 9), and no significant change in Na<sup>+</sup> concentration (Embryo Nos. 2, 4, 6, 8). …”
-
377
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
Published 2025“…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …”
-
378
-
379
-
380
Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
Published 2025“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”